Daniel Loeb’s Third Point sold its remaining stake in Cano Health amid concerns around the company’s liquidity, Rachel Butt and Scott Deveau of Bloomberg report, citing people with knowledge of the situation. Third Point sold out of Cano through a block trade last week, said sources told Bloomberg. The hedge fund had disclosed a 3.5% position in October, down from 6.4% in March, the journalists note, citing public filings show. In addition, some of Cano Health’s biggest creditors are in the early stages of organizing ahead of potential debt discussions, people told Bloomberg.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CANO:
- Cano Health downgraded at Cowen with liquidity ‘now a plausible 2023 concern’
- Cano Health downgraded to Market Perform from Outperform at Cowen
- Cano Health downgraded to Market Perform from Outperform at Raymond James
- Cano Health lowers FY22 revenue view to $2.70B-$2.75B from $2.85B-$2.90B
- Cano Health reports Q3 EPS (23c), consensus (5c)